Bausch Health
315 hedge funds and large institutions have $2.9B invested in Bausch Health in 2016 Q4 according to their latest regulatory filings, with 63 funds opening new positions, 97 increasing their positions, 100 reducing their positions, and 86 closing their positions.
3% less repeat investments, than reductions
Existing positions increased: 97 | Existing positions reduced: 100
7.31% less ownership
Funds ownership: 65.72% → 58.41% (-7.3%)
9% less funds holding
Funds holding: 346 → 315 (-31)
27% less first-time investments, than exits
New positions opened: 63 | Existing positions closed: 86
45% less call options, than puts
Call options by funds: $477M | Put options by funds: $861M
46% less funds holding in top 10
Funds holding in top 10: 24 → 13 (-11)
48% less capital invested
Capital invested by funds: $5.61B → $2.9B (-$2.71B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MVP
Miller Value Partners
Sarasota,
Florida
|
+$47M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$46.9M |
| 3 |
Renaissance Technologies
New York
|
+$45.5M |
| 4 |
Two Sigma Advisers
New York
|
+$36.5M |
| 5 |
FI
Fosun International
Hong Kong,
China
|
+$28.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
PointState Capital
New York
|
-$209M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$97M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$84.8M |
| 4 |
Morgan Stanley
New York
|
-$75.1M |
| 5 |
GA
Glenhill Advisors
New York
|
-$64M |
BHC Hedge Fund Activity: Q4 2016 in Review
315 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q4 2016, worth a combined $2.9B — down 48% from $5.61B a quarter earlier.
Sellers outnumbered buyers: 86 funds closed out of BHC and 63 opened new positions — a net loss of 23 holders — while 100 trimmed existing stakes and 97 added.
The largest buyer was Miller Value Partners, adding an estimated $47M. The largest seller was PointState Capital, exiting entirely with an estimated $209M sold.
- 315 institutional investors held Bausch Health (BHC) as of Q4 2016, down from 346 in Q3 2016.
- Funds reported $2.9B of Bausch Health stock for Q4 2016, down 48% quarter-over-quarter.
- 63 funds opened new Bausch Health positions in Q4 2016 and 86 closed out, a net change of -23 holders.
- The largest Bausch Health buyer in Q4 2016 was Miller Value Partners, an estimated $47M added.
- The largest Bausch Health seller in Q4 2016 was PointState Capital, an estimated $209M sold.
Based on aggregated 13F filings for Q4 2016.